Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of its TrailBlazer™ Tag and TrailBlazer ...
The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.